Please wait while the formulary information is being retrieved.
ALLERGY EYE (NAPHAZOLINE HCL/PHENIRAMINE MALEATE)
- Ocular itching
- Ocular redness
- Naphcon-a Eye Drops
- Eye Allergy Relief (naphazoline-pheniramine) Drops
- Allergy Eye (naphazoline-pheniramine) Drops
0.025 %-0.3 % eye drops
- Dosage information is not available
(naphazoline-pheniramine) 0.025 %-0.3 % drops
- Dosage information is not available
(naphazoline-pheniramine) 0.02675 %-0.315 % drops
- Dosage information is not available
(naphazoline-pheniramine) 0.025 %-0.3 % drops
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- Angle-closure glaucoma
Contraindicated
- None
Severe
Moderate
- Diabetes mellitus
- Hypertension
- Hyperthyroidism
- Ocular infection
- Ocular injury
ALLERGY EYE (NAPHAZOLINE HCL/PHENIRAMINE MALEATE)
- Ocular itching
- Ocular redness
- None
- None
More Frequent
Severe
Less Severe
- None
- Blurred vision
- Mydriasis
- Ocular irritation
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Dizziness
- Hyperhidrosis
- Hypertension
- Ocular hypertension
- Punctate keratitis
Less Severe
- Drowsy
- General weakness
- Headache disorder
- Hyperglycemia
- Nausea
- Nervousness
- Photophobia
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Naphazoline (Ophth)
Risk of CNS depression. Consult clinician for use in children age < 6 years.
- 1 Day – 6 Years
- Risk of CNS depression. Consult clinician for use in children age < 6 years.
Naphazoline Hydrochloride
- Severity Level:
C
- Additional Notes: Insufficient data available
Pheniramine Maleate
- Severity Level:
2
- Additional Notes: Antihist use last 2 wks of preg assoc w/retrolental fibroplasia in premature inf
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Naphazoline Hydrochloride
Insufficient data available.
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available. |
Pheniramine
Insufficient data available.
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available. |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Ocular itching | |
| H57.89 | Other specified disorders of eye and adnexa |
| L29.8 | Other pruritus |
| Ocular redness | |
| H57.8 | Other specified disorders of eye and adnexa |
| H57.89 | Other specified disorders of eye and adnexa |
| 0-9 | A-Z |
|---|---|
| H57.8 | Other specified disorders of eye and adnexa |
| H57.89 | Other specified disorders of eye and adnexa |
| H57.89 | Other specified disorders of eye and adnexa |
| L29.8 | Other pruritus |
Formulary Reference Tool